Virtu Financial’s BioCardia BCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25K Buy
+20,355
New +$25.5K ﹤0.01% 1367
2024
Q2
Sell
-937
Closed -$6K 1318
2024
Q1
$6K Sell
937
-1,820
-66% -$13K ﹤0.01% 1281
2023
Q4
$27K Buy
+2,757
New +$22.4K ﹤0.01% 1271
2022
Q1
Sell
-3,761
Closed -$109K 1497
2021
Q4
$109K Buy
+3,761
New +$138K 0.01% 1097
2021
Q3
Sell
-2,218
Closed -$132K 1507
2021
Q2
$132K Buy
+2,218
New +$135K 0.01% 1127

Other funds holding BCDA

Virtu Financial's BCDA Position: Q1 2026 in Review

Virtu Financial opened a new position in BioCardia (BCDA) in Q1 2026: 20,355 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #1367 among its holdings. This is a return to the name: Virtu Financial previously reported a position in BCDA as recently as Q1 2024.

Virtu Financial first reported a position in BCDA in Q2 2021 and has held it in 5 quarters since. The position peaked at $132K in Q2 2021. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • Virtu Financial held 20,355 shares of BioCardia worth $25K as of Q1 2026.
  • BioCardia was a new Virtu Financial position in Q1 2026.
  • BioCardia made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1367 holding.
  • Virtu Financial first reported a position in BioCardia in Q2 2021 and has held it in 5 quarters since.
  • Virtu Financial's BioCardia position peaked at $132K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.